American Association for Cancer Research
Browse
00085472can153046-sup-157847_1_supp_3327729_n1lnyp.docx (26.73 kB)

Supplemental Material and Methods from Noninvasive In Vivo Imaging and Biologic Characterization of Thyroid Tumors by ImmunoPET Targeting of Galectin-3

Download (26.73 kB)
journal contribution
posted on 2023-03-31, 00:07 authored by Calogero D'Alessandria, Sten Braesch-Andersen, Kristel Bejo, Sybille Reder, Birgit Blechert, Markus Schwaiger, Armando Bartolazzi

Description of additional methods and procedures used in the study.

Funding

ERC

Deutsche Forschungsgemeinschaft

AIRC

History

ARTICLE ABSTRACT

The high prevalence of thyroid nodules in the adult population and the relatively low incidence of thyroid cancer make the preoperative identification of malignant lesions challenging. The β-galactoside–binding protein galectin-3 is widely expressed in well-differentiated thyroid carcinomas, but not in normal thyrocytes and benign thyroid nodules. This molecule offers a candidate biomarker to improve thyroid cancer diagnosis. Here we report the development of an immunoPET approach for noninvasive imaging of thyroid cancer. The method employs a 89Zr-labeled mAb to galectin-3, which shows high specificity and binding affinity in vitro. Reliable and specific immunoPET imaging was obtained of thyroid cancer in vivo in murine xenograft models of human thyroid cancer. Our findings provide a method to improve the clinical management of patients with thyroid nodules while reducing unnecessary surgery and social costs. Cancer Res; 76(12); 3583–92. ©2016 AACR.

Usage metrics

    Cancer Research

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC